Evidence map›Paper›PMID 36259364›Full record

ArticleChemMedChem2023

Synthesis of a Bifunctional Cross-Bridged Chelating Agent, Peptide Conjugation, and Comparison of

Helen Damerow, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler

Open access · greenAbstract read
In one paragraph

Article in ChemMedChem, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Helen DamerowClinic of Radiology and Nuclear Medicine, Biomedical Chemistry, Medical Faculty Mannheim of Heidelberg University, 68167, Mannheim, Germany.
Björn WänglerClinic of Radiology and Nuclear Medicine, Molecular Imaging and Radiochemistry, Medical Faculty Mannheim of Heidelberg University, 68167, Mannheim, Germany.ORCID 0000-0003-3877-5576
Ralf SchirrmacherDepartment of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, AB, T6G 1Z2, Canada.ORCID 0000-0002-7098-3036
Gert FrickerInstitute of Pharmacy and Molecular Biotechnology, University of Heidelberg, 69120, Heidelberg, Germany.
Carmen WänglerClinic of Radiology and Nuclear Medicine, Biomedical Chemistry, Medical Faculty Mannheim of Heidelberg University, 68167, Mannheim, Germany.ORCID 0000-0003-1161-8669
Heidelberg University · DEUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[

Indexed as

Chelating AgentsPositron-Emission TomographyPeptidesPeptides, CyclicChelating AgentsPeptidesPeptides, Cyclic68GaCB-DO2A-GApeptide conjugationradiochemistryradiolabeling efficiency

Identifiers

PMID36259364
PMCPMC10100262
OpenAlexW4306777500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.